CN Patent

CN104814961A — 含有氟喹诺酮抗生素药物的药物组合物

Assigned to Novartis AG · Expires 2015-08-05 · 11y expired

What this patent protects

公开了含有氟喹诺酮抗生素药物的药物组合物。该组合物显示出改善的均匀性、改善的生物利用度、较低的浊度或其组合。该组合物可用作耳用或鼻用组合物，但是特别可用作眼用组合物。

USPTO Abstract

公开了含有氟喹诺酮抗生素药物的药物组合物。该组合物显示出改善的均匀性、改善的生物利用度、较低的浊度或其组合。该组合物可用作耳用或鼻用组合物，但是特别可用作眼用组合物。

Drugs covered by this patent

moxifloxacin-hydrochloride (MOXIFLOXACIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN104814961A
Jurisdiction: CN
Classification: —
Expires: 2015-08-05
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.